title: Prevalence of hepatitis G virus RNA in a monocentric population of French haemophiliacs.
abstract: Hepatitis G virus (HGV) and hepatitis GB virus (GBV-C) have been reported as possible causes of non-A-E transfusional hepatitis. To assess the prevalence of hepatitis G virus infection in haemophiliacs we retrospectively investigated the presence of viral RNA in 92 patients with and without HCV infection. HGV/GBV-C RNA was reverse transcribed and amplified with primers from the 5' non-coding region of the genome. RNA was detected in 16/92 patients (17.4%). Restriction enzyme analysis revealed that the 16 patients belonged to the HGV-like genotype. Serology with E2-specific antibodies demonstrated that HGV viraemia underestimates previous infection by HGV. 33 patients were positive for HGV; all but two have cleared HGV RNA. 47/92 patients had a marker of prior infection by HGV. No difference between HGV RNA positive and negative patients was observed concerning age, diagnosis, HIV and HCV status. Previous HBV infection correlated with the frequency of HGV infection. There was no difference in alanine aminotransferase levels between HGV positive and negative patients. All 18 patients exposed to only virally inactivated plasma-derived concentrates were negative for both HGV RNA and anti E2 antibodies. Prior exposure to untreated concentrates correlated with HGV viraemia (P=0.03), HGV seropositivity (P=0.0002), and markers of HGV infection (P<0.0001). In haemophiliacs with a past exposure to non-inactivated concentrates, persistence of HCV RNA (53/74 patients) was more frequent than HGV RNA persistence (16/74 patients) although HGV viraemia is more frequent than HCV viraemia in blood donors. This may be related to a greater ability of individuals to clear HGV infection and suggests that hepatitis G virus infection in multi-transfused patients has a better outcome than infection with other blood-borne viruses.
authors.affiliation: Laboratoire de Biochimie, CHR Conception, Marseille, France.
authors.forename: V
authors.initials: V
authors.lastname: Gerolami
authors.forename: P
authors.initials: P
authors.lastname: Halfon
authors.forename: H
authors.initials: H
authors.lastname: Chambost
authors.forename: F
authors.initials: F
authors.lastname: Sicardi
authors.forename: I
authors.initials: I
authors.lastname: Thuret
authors.forename: R
authors.initials: R
authors.lastname: Planells
authors.forename: G
authors.initials: G
authors.lastname: Halimi
authors.forename: C
authors.initials: C
authors.lastname: Fossat
authors.forename: G
authors.initials: G
authors.lastname: Michel
authors.forename: G
authors.initials: G
authors.lastname: Cartouzou
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D018067:Flaviviridae / Q000235:genetics*; D006467:Hemophilia A / Q000453:epidemiology* / Q000821:virology; D006525:Hepatitis, Viral, Human / Q000453:epidemiology* / Q000235:genetics; D006801:Humans; D008875:Middle Aged; D015995:Prevalence; D012367:RNA, Viral / Q000302:isolation & purification*; D012189:Retrospective Studies
chemical_list: D012367:RNA, Viral